Back

The risk of all-cause death after COVID-19 hospital admission among patients with prior heart failure, chronic kidney disease and cardiorenal syndrome: a 12 month follow-up observational study

29 June 2021 (08:00 - 08:00)
Organised by:
Congress Presentation Part of: Registry Updates Comorbidities HFA Premium Access Heart Failure 2021

About the speaker

Photo
Doctor Johan Bodegard

RWE Research, Oslo (Norway)

10 More presentations in this session

Presentation thumbnail
SCD and ventricular event rates in a Japanese population: Primary results from the Heart Failure Indication and Sudden Cardiac Death Prevention Trial
Doctor K. Aonuma (Tsukuba, JP)
Slides Video
Presentation thumbnail
Clinical course and related costs of patients with type 2 diabetes and heart failure and/or chronic kidney disease, drawn from a sample of more than 7 million people
Doctor A. Maggioni (Florence, IT)
Slides Video
Presentation thumbnail
Potential Implications of Expanded FDA Labeling for Sacubitril/Valsartan in the United States
Doctor M. Vaduganathan (Boston, US)
Slides Video
Presentation thumbnail
Prescription Fill Patterns of Guideline-Directed Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States
Doctor M. Vaduganathan (Boston, US)
Slides Video
Presentation thumbnail
Higher Alkaline Phosphatase Mean and Variability Predict Heart Failure and All-cause Mortality
Ms S. Lee (Hong Kong, CN)
Slides Video

Access the full session

Session thumbnail
Registry Updates

The Event

Event poster

Heart Failure 2021

29 June 2021 08:00 CET
You may be interested in
thumbnail
Congress Session
Chronic kidney disease and heart failure
thumbnail
Congress Presentation
Spectrum of non-cardiac comorbidities
thumbnail
Congress Presentation
Clinical characteristics of newly diagnosed vs. chronic heart failure patients in Spain: SEC-Excelente registry results.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources